Floatz logo

Canfosfamide

B-Cell Non-Hodgkin Lymphoma

TelikSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

306 Active assets in the B-Cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
Vindesine
Children's Cancer Group, China
Phase 4BBB
ANTI-CD20/CD3 MONOCLONAL ANTIBODY REGN1979
University of Birmingham
Phase 3BBB
METHOTREXATE
Children's Cancer Group, China
Phase 4BBB
Cytarabine
Children's Cancer Group, China
Phase 4BBB
ISOCYCLOPHOSPHAMIDE
Shanghai Junshi Bioscience Co., Ltd.
Phase 4BBB

View all 50 →

Same molecule, other indications

Canfosfamide is also rated in:

ovarian neoplasmDormant
BB
Indicative · Phase 3
69 / 100
View asset →
non-small cell lung carcinomaDormant
B
Indicative · Phase 3
63 / 100
View asset →
primary peritoneal carcinomaDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →